Provider-supervised catalog
Metabolic-health treatments support blood-sugar control and related metabolic function with medications like metformin and acarbose. You pick the precise strength up front, and an independent, licensed U.S. provider reviews every order before anything is prescribed.
3 treatments
Extended-Release 500–1000 mg Tablets
Extended-release metformin for blood sugar support. A gradual-release format prescribed as part of a provider-directed metabolic plan.
3 strengths available
from $39.99
Choose options
Immediate-Release 250–1000 mg Tablets
Immediate-release metformin, a long-established option for blood sugar support. Prescribed and monitored by a licensed provider.
4 strengths available
from $34.00
Choose options
Acarbose 25–100 mg Tablets
An oral medication that slows carbohydrate breakdown in the gut, easing post-meal glucose spikes. Prescribed within a provider-directed metabolic plan.
3 strengths available
from $34.99
Choose optionsHow metformin works: the biguanide mechanism
A neutral, mechanism-focused look at how metformin, a biguanide, is understood to act on the liver, insulin sensitivity, and AMPK signaling.
How acarbose is understood to work: the alpha-glucosidase inhibitor pathway
A neutral, mechanism-focused look at how acarbose, an alpha-glucosidase inhibitor, is understood to act on the enzymes that digest carbohydrates in the small intestine.
Extended-release vs. immediate-release metformin: how the formulations differ
A neutral, formulation-focused look at how extended-release and immediate-release metformin differ in the way each tablet releases the drug, and how that shapes absorption over time.
Low-dose naltrexone (LDN): the history and proposed mechanism
A plain-language history of naltrexone — how it was developed as an opioid antagonist — and the low-dose opioid-rebound and immune-modulation mechanisms studied in research.
What incretins are: GIP, GLP-1, and the hormones behind dual-action medications
A plain-language look at the gut hormones behind incretin-based medications — what GIP, GLP-1, and glucagon are, and why one dual-action molecule is designed to engage two of these pathways at once.
Insulin resistance: how insulin sensitivity is understood to work
A neutral, mechanism-focused look at how insulin normally signals cells to take up glucose, and what researchers mean when tissues become less responsive to that signal.
How blood sugar is regulated: insulin, glucagon, and glucose homeostasis
A neutral, mechanism-focused look at how the pancreas, liver, and the opposing hormones insulin and glucagon are understood to keep blood glucose within a narrow range.
Brown fat and thermogenesis: how the body generates heat
A plain-language look at how brown adipose tissue and the UCP1 protein are understood to turn stored fuel into body heat, distinct from white fat's storage role.
The gut-brain axis: how the digestive tract signals the brain
A neutral, mechanism-focused look at how enteroendocrine cells, gut hormones, and the vagus nerve are understood to carry information about food between the digestive tract and the brain.
Gastric emptying: how the stomach paces digestion
A plain-language, mechanism-focused look at how the stomach's muscle, the pyloric sphincter, and feedback from the duodenum are understood to control the rate at which food leaves the stomach and reaches the intestine.
